NCT07885761
REVIVE-FR Registry
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Stopped Withdrawn before enrolling Sponsor's reason: Sponsor Change
- Enrollment target: estimated 200 to confirmed 0
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
Endpoints
Primary
Secondary (6)
Show 1 moreShow less
Arms and interventions
transfemoral THV implantation into a failed surgical bioprosthesis, any VARC-3 failure mechanism.
transfemoral THV implantation into a failed THV, SVD-driven failure (VARC-3 Stage II/III)
surgical explantation of a failed THV, enrolled directly within REVIVE-FR (not as an external comparator)
failing THV due to SVD or endocarditis, managed conservatively (i.e., without TAVI-in-SAVR, THV-in-THV, or surgical explantation); a descriptive, real-world reference cohort, not powered for statistical comparison with the interventional cohorts
Procedures: TAVI-in-SAVR (Valve-in-Valve), THV-in-THV (Redo-TAVI), Surgical Explantation of a Failed Transcatheter Heart Valve
Other: Medical management